Aaronson, S. A., Todaro, G. J. & Scholnick, E. M., 1971. Induction of murine C-type viruses from clonal lines of virus-free BALB/3T3 cells. Science 174:157-159. Agbalika, F., Ferchal, F., Garnier, J. P., Eugene, M., Bedrossian, J. & Lagrange, P. H., 1992. False-positive HIV antigens related to emergence of a 25-30kD proteins detected in organ recipients. AIDS 6:959-962. Allain, J. P., 1986. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France. NEJM 315:517. Allain, J. P., Laurian, Y., Paul, D. A., Verroust, F., Leuther, M., Gazengel, C., Senn, D., Larrieu, M. J. & Bosser, C., 1987. Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. NEJM 317:1114-1121. Andrews, C. A., Sullivan, J. L., Brettler, D. B., Brewster, F. E., Forsberg, A. D., Scesney, S. & Levine, P. H., 1987. Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities. J. Pediatr. 111:672-677. Anonymous, 1987. CDC definition inadequate to handle growing cases, scientists complain. AIDS Alert July:120-121. Aronson, D. L., 1983. Pneumonia deaths in haemophiliacs. Lancet II:1023. Barthel, H. R. & Wallace, D. J., 1993. False-positive human immunodeficiency virus testing in patients with lupus erythematosus. Sem. Arthrit. Rheumat. 23:1-7. Bauer, H., Daams, J. H., Watson, K. F., Molling, K., Gelderblom, H. & Schafer, W., 1974. Oncornavirus-like particles in HeLa cells. II. Immunological characterization of the virus. Int. J. Cancer 13:254-261. Beeser, H., 1991. Characterization of highly purified factor VIII products. Ann. Hematol. 63:126-130. Beral, V., Peterman, T. A., Berkelman, R. L. & Jaffe, H. W., 1990. Kaposi's sarcoma among persons with AIDS:a sexually transmitted infection? Lancet 335:123-128. Biggar, R. J., 1986. Possible nonspecific associations between malaria and HTLV-III/LAV. NEJM 315:457. Blattner, W. A. 1989. Retroviruses. pp. 545-592, in Viral infections of humans, 3rd Edition, edited by A. S. Evans, Plenum Medical Book Company, New York. Bolognesi, D., 1990. Vaccine development for HIV infection. J. Am. Acad. Dermatol. 22:1295-1299. Brenner, B., Schwartz, S., Ben-Porath, E., Tatarsky, I., Varon, D. & Martinowitz, U., 1991. The prevalence and interaction of human immunodeficiency virus and hepatitis B infections in Israeli hemophiliacs. Isr. J. Med. Sci. 27:557-561. Brettle, R. P., Gore, S. M., Bird, A. G. & McNeil, A. J., 1993. Clinical and epidemiological implications fo the Centers for Disease Control/World Health Organization reclassifaction of AIDS cases. AIDS 7:531-539. Brettler, D. B., Forsberg, A. D., Levine, P. H., Andrews, C. A., Baker, S. & Sullivan, J. L., 1988. Human immunodeficiency virus isolation studies and antibody testing. Arch. Int. Med. 148:1299-1301. Burke, B. A. & Good, R. A., 1973. Pneumocystis carinii infection. Medicine 52:23-50. Callaham, M. L., 1991. Prophylaxis with zidovudine (AZT) after exposure to human immunodeficiency virus: a brief discussion of the issues for emergency physicians. Ann. Emerg. Med. 20:1351-1354. Callebaut, C., Krust, B., Jacotot, E. & Hovanessian, A. G., 1993. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science 262:2045-2050. CDC. 1981. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California. MMWR 30:305-307. CDC. 1982. Epidemiological aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections. NEJM 306:248-252. CDC. 1982. Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR 31:365-367. CDC. 1982. Update on acquired immune deficiency syndrome (AIDS)-United States. MMWR 31:507-514. CDC. 1982. Update on Kaposi's Sarcoma and Opportunistic Infections in Previously Healthy Persons-United States. MMWR 31:294-301. CDC. 1987. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. JAMA 258:1143-1154. CDC. 1987. Survey of non-U.S. hemophilia treatment centers for HIV seroconversions following therapy with heat-treated factor VIII concentrates. MMWR 36:121-124. CDC. 1991. Mortality attributable to HIV infection/AIDS-United States, 1981-1990. MMWR 40:41-44. CDC. 1992. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 41:1-19. CDC 1994. Facts about the human immunodeficiency virus and its transmission. CDC HIV/AIDS Prevention. January. Chang, L. J., Pryciak, P., Ganem, D. & Varmus, H. E., 1989. Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribsomal frameshifting. Nature 337:364-368. Chopra, H. C. & Feller, W. F., 1969. Viruslike particles in human breast cancer. Texas Rep. Biol. Med. 27:945-953. Clark, S. J., Saag, M. S., Decker, W. D., Campbell-Hill, S., Roberson, J. L., Veldkamp, P. J., Kappes, J. C., Hahn, B. H. & Shaw, G. M., 1991. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. NEJM 324:954-960. Cohen, J., 1993. Unlikely Recruit: Andrew Leigh Brown. Science 260:1264. Conway, B. 1990. Detection of HIV-1 by PCR in Clinical Specimens. pp. 40-45, in Techniques in HIV Research, edited by A. Aldovini and B. D. Walker, Macmillan, New York. Conway, B., Baskar, P., Bechtel, L. J., Kaplan, J. C., Hirsch, M. S., Schooley, R. T. & Pincus, S. H., 1992. Eosinophils as host cells for HIV-1. J Arch Virol 127:373-377. Coombs, R. W., Collier, A. C., Allain, J. P., Nikora, B., Leuther, M., Gjerset, G. & Corey, L., 1989. Plasma viremia in human immunodeficiency virus infection. NEJM 321:1626-1631. Damjanovic, V., 1987. What makes human immunodeficiency virus (HIV) resistant to dry heat inactivation. J. Hosp. Infect. 10:209-210. Damjanovic, V., 1989. Haemophiliacs with HIV seroconversion associated with heat-treated products: are they actively infected? JAMA 261:1275. Daniel, V., Schimpf, K. & Opelz, G., 1989. Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients. Clin. Exp. Immunol. 75:178-183. Darby, S. C., Doll, R., Thakrar, B., Rizza, C. R. & Cox, D. R., 1990. Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Stat. Med. 9:681-689. Darby, S. C., Rizza, C. R., Doll, R., Spooner, R. J. D., Stratton, I. M. & Thakrar, B., 1989. Incidence of AIDS and excess mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. Br. Med. J 298:1064-1068. Dewar, R. L., Sarmiento, M. D., Lawton, E. S., Clark, H. M., Kennedy, P. E., Shah, A., Baseler, M., Metcalf, J. A., Lance, H. C. & Salzman, N. P., 1992. Isolation of HIV-1 from plasma of infected individuals: an analysis of experimental conditions affecting successful virus propogation. J. Acquir. Immune Defic. Syndr. 5:822-828. Duesberg, P. H., 1992. AIDS acquired by drug consumption and other noncontagious risk factors. Pharmac. Ther. 55:201-277. Esiri, M. M., Scaravilli, F., Millard, P. R. & Harcourt-Webster, J. N., 1989. Neuropathology of HIV infection in haemophiliacs: comparative necrospy study. Br. Med. J. 299:1312-1315. Evatt, B. L., Gomperts, E. D., McDougal, J. S. & Ramsey, R. B., 1985. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. NEJM 312:483-486. Eyster, M. E., Gail, M. H., Ballard, J. O., Al-Mondhiry, H. & Goedert, J. J., 1987. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann. Int. Med. 107:1-6. Eyster, M. E. & Nau, M. E., 1978. Particulate material in antihemophiliac factor (AHF) concentrates. Transfusion September-October:576-581. Eyster, M. E., Whitehurst, D. A., Catalano, P. M., McMillan, C. W., Goodnight, S. H., Kasper, C. K., Gill, J. C., Aledort, L. M., Hilgartner, M. W., Levine, P. H., Edson, J. R., Hathaway, W. E., Lusher, J. M., Gill, F. M., Poole, W. K. & Shapiro, S. S., 1985. Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood 66:1317-1320. Fernandez-Palazzi, F., de Bosch, N. B. & de Vargas, A. F., 1984. Radioactive synovectomy in haemophilic haemarthrosis. Follow-up of fifty cases. Scand. J. Haematol. 33:291-300. Follansbee, S. E., Busch, D. F., Wofsy, C. B., Coleman, D. L., Gullet, J., Aurigemma, G. P., Ross, T., Hadley, W. K. & Drew, L., 1982. An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann. Int. Med. 96:705-713. Gallo, R. C., 1986. The First Human Retrovirus. Sci. Am. 255:78-88. Gallo, R. C., 1987. The AIDS virus. Sci. Am. 256:38-48. Gallo, R. C. & Montagnier, L., 1988.AIDS in 1988. Sci. Am. 259:24-32. Gallo, R. C., Sarin, P. S. & Wu, A. M. 1973. On the nature of the Nucleic Acids and RNA Dependent DNA Polymerase from RNA Tumor Viruses and Human Cells. pp. 13-34, in Possible Episomes in Eukaryotes, edited by L. G. Silvestri, North-Holland Publishing Company, Amsterdam. Goedert, J. J., Kessler, C. M., Aledort, L. M., Biggar, R. J., Abe Andes, W., White II, G. C., Drummond, J. E., Vaidya, K., Mann, D. L., Eyster, M. E., Ragni, M. V., Lederman, M. M., Cohen, A. R., Bray, G. L., Rosenberg, P. S., Friedman, R. M., Hilgartner, M. W., Blattner, W. A., Kroner, B. & Gail, M. H., 1989. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. NEJM 321:1141-1148. Gomperts, E. D., 1990. HIV infection in hemophiliac children: clinical manifestations and therapy. Am. J. Ped. Hematol/Oncol. 12:497-504. Gomperts, E. D., Feorino, P., Evatt, B. L., Warfield, D., Miller, R. & McDougal, J. S., 1985. LAV/HTLV III presence in peripheral blood lymphocytes of seropositive young hemophiliacs. Blood 65:1549-1552. Gougeon, M. L., Laurent-Crawford, A. G., Hovanessian, A. G. & Montagnier, L., 1993. Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. Immunol. 5:187-194. Greenspan, J. S. & Greenspan, D. 1989. Hairy leukoplakia and other oral features of HIV infection. pp. 449-465, in AIDS Pathogenesis and Treatment, 1st Edition, edited by J. A. Levy, Marcel Dekker Inc., New York. Haseltine, W. A. & Wong-Staal, F., 1988. The molecular biology of the AIDS virus. Sci. Am. 259:34-42. Hausmann, E. H. S., Gelderblom, H. R., Clapham, P. R., Pauli, G. & Weiss, R. A., 1987. Detection of HIV envelope specific proteins by immunoelectron microscopy and correlation with antibody titer and virus neutralizing activity. J. Virol. Meth. 16:125-137. Helmer, R. E., Alperin, J. B., Yunginger, J. W. & Grant, J. A., 1980. Anaphylactic reactions following infusion of factor VIII in a patient with classic hemophilia. Am. J. Med. 69:953-957. Hilfenhaus, J. W., Gregersen, J. P., Mehdi, S. & Volk, R., 1990. Inactivation of HIV-1 and HIV-2 by various manufacturing procedures for human plasma proteins. Cancer Detect. Prev. 14:369-375. Hilgartner, M. W., 1987. AIDS and hemophilia. NEJM 317:1153-1154. Hirsch, M. S., Phillips, S. M. & Solnik, C., 1972. Activation of Leukemia Viruses by Graft-Versus-Host and Mixed Lymphocyte Reactions In Vitro. Proc. Nat. Acad. Sci. 69:1069-1072. Ho, D. D., Moudgil, T. & Alam, M., 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. NEJM 321:1621-1625. Hollan, S. R., Fust, G., Nagy, K., Horvath, A., Krall, G., Verebelyi, K., Ujhelyi, E., Varga, L. & Mayer, V., 1985. Immunological alterations in anti-HTLL-III negative haemophiliacs and homosexual men in Hungary. Immunol. Lett. 11:305-310. Hooks, J., Gibbs, C. J., Chopra, H., Lewis, M. & Gajdusek, D. C., 1972. Spontaneous transformation of human brain cells grown in vitro and description of associated virus particles. Science 176:1420-1422. Horwitz, M. S., Boyce-Janino, M. T. & Faras, A. J., 1992. Novel human endogenous sequences related to human immunodeficiency virus type 1. J. Virol. 66:2170-2179. Hughes, W. T., 1987. Pnuemocystis carinii pneumonitis. NEJM 317:1021-1023. Jackson, J. B., 1989. Haemophiliacs with HIV seroconversion associated with heat-treated products: are they actively infected? (Reply). JAMA 261:1275. Jackson, J. B., Sannerud, K. J. & Balfour, H. H., 1989. Comparison of two serum HIV antigen assays for selection of asymptomatic antigenemic individuals into clinical trials. J. Acquir. Immune Defic. Syndr. 2:394-397. Jackson, J. B., Sannerud, K. J., Hopsicker, J. S., Kwok, S. Y., Edson, J. R. & Balfour, H. H., 1988. Hemophiliacs with HIV antibody are actively infected. JAMA 260:2236-2239. Jason, J. J., McDougal, S., Holman, R. C., Stein, S. F., Lawrence, D. N., Nicholson, J. K. A., Dixon, G., Doxey, M. & Evatt, B. L., 1985. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. JAMA 253:3409-3415. Jason, J. M., Evatt, B., Chorba, T. L. & Ramsey, R. B., 1984. Acquired immunodeficiency syndrome (AIDS) in hemophiliacs. Scand. J. Haematol. 33:349-356. Jason, J. M., McDougal, J. S., Dixon, G., Lawrence, D. N., Kennedy, M. S., Hilgartner, M., Aledort, L. & Evatt, B. L., 1986. HTLV-III/LAV Antibody and Immune Status of Household Contacts and Sexual Partners of Persons with Hemophilia. JAMA 255:212-215. Johnson, R. E., Lawrence, D. N., Evatt, B. L., Bregman, D. J., Zyla, L. D., Curran, J. W., Aledort, L. M., Eyster, M. E., Browstein, A. P. & Carman, C. J., 1985. Acquired immunodeficiency syndrome among patients attending hemophilia treatment centers and mortality experience of hemophiliacs in the United States. Am. J. Epidemiol. 121:797-810. Jones, P., Hamilton, P. J., Bird, G., Fearns, M., Oxley, A., Tedder, R., Cheingsong-Popov, R. & Codd, A., 1985. AIDS and haemophilia: morbidity and mortality in a well defined population. Br. Med. J. 291:695-699. Kessler, C. M., Schulof, R. S., Goldstein, A. L., Naylor, P. H., Luban, N. L., Kelleher, J. F. & Reaman, G. H., 1983. Abnormal T-Lymphocyte Subpopulations Associated with Transfusions of Blood-Dertived Products. Lancet I:991-992. Kitchen, L. W., Barin, F., Sullivan, J. L., McLane, M. F., Brettler, D. B., Levine, P. H. & Essex, M., 1984. Aetiology of AIDS-antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature 312:367-369. Koerper, M. 1989. AIDS and hemophilia. pp. 79-95, in AIDS Pathogenesis and Treatment, 1st Edition, edited by J. A. Levy, Marcel Dekker Inc., New York. Kopitsky, R. G. & Geltman, E. M., 1986. Unstable angina associated with factor VIII concentrate therapy for hemophilia A. Ann. Int. Med. 105:215-216. Kozhemiakin, L. A. & Bondarenko, I. G., 1992. Genomic instability and AIDS. Biochimiia 57:1417-1426. Lane, R. J. M., McLean, K. A., Moss, J. & Woodrow, D. F., 1993. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Neuropath. App. Neurobiol. 19:406-413. Lauritsen, J., 1990. Poison by prescription-The AZT story. Asklepois Press, New York. Lawrence, D. N., Jason, J. M., Holman, R. C., Heine, P. & Evatt, B. L., 1989. Sex practice correlates of human immunodeficiency virus transmission and acquired immunodeficiency syndrome incidence in heterosexual partners and offspring of U.S. hemophilic men. A. J. Hematol. 30:68-76. Lazcano, A., Valverde, V., Hernandez, G., Gariglio, P., Fox, G. E. & Oro, J., 1992. On the early emergence of reverse transcription: theoretical basis and experimental evidence. J. Mol. Evol. 35:524-536. Levine, P. H., 1985. The acquired immunodeficiency syndrome in persons with hemophilia. Ann. Int. Med. 103:723-726. Levine, P. H., Horoszewicz, J. S., Grace, J. T., Chai, L. S., Ellison, R. R. & Holland, J. F., 1967. Relationship between clinical status of leukemic patients and virus-like particles in their plasma. Cancer 20:1563-1577. Levy, J. A., 1988. The transmission of AIDS: the case of the infected cell. JAMA 259:3037-3038. Levy, J. A., 1989. AIDS Pathogenesis and Treatment. Marcel Dekker, Inc., New York. Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M. & Oshiro, L. S., 1984. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225:840-842. Levy, J. A., Mitra, G. & Mozen, M. M., 1984. Recovery and inactivation of infectious retroviruses added to factor VIII concentrates. Lancet II:722-733. Levy, J. A., Mitra, G. A., Wong, M. F. & Mozen, M. M., 1985. Inactivation by wet and dry heat of AIDS-associated retroviruses during factor VIII purification from plasma. Lancet I:1456-1457. Lewis, B. J., Abrell, J. W., Smith, R. G. & Gallo, R. C., 1974. Human DNA polymerase III (R-DNA): Distinction from DNA polymerase I and reverse transcriptase. Science 183:867-869. Lian, E. C. Y., Larcada, A. F. & Chiu, A. Y. Z., 1989. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann. Int. Med. 110:774-778. Lower, R. & Lower, J., 1993. Endogenous retrovirus sequences in human teratocarcinoma cell lines. J. Acquir. Immune Defic. Syndr. 6:738. Ludlam, C. A., Steel, C. M., Cheingsong-Popov, R., McClelland, D. B. L., Tucker, J., Tedder, R. S., Weiss, R. A., Philip, I. & Prescott, R. J., 1985. Human T-Lymphotropic Virus Type-III (HTLV-III) Infection in Seronegative Haemophiliacs after Transfusion of Factor VIII. Lancet II:233-236. Lundberg, G. D., 1988. Serological Diagnosos of Human Immunodeficiency Virus Infection by Western Blot Testing. JAMA 260:674-679. Madhok, R., Gracie, A., Lowe, G. D., Burnett, A., Froebel, K., Follett, E. & Forbes, C. D., 1986. Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br. Med. J. Clin. Res. 293:978-980. Mak, T. W., Manaster, J., Howatson, A. F., McCullough, E. A. & Till, J. E., 1974. Particles with characteristics of leukoviruses in cultures of marrow cells from leukemic patients in remission and relapse. Proc. Natl. Acad. Sci. USA 71:4336-4340. Mannucci, P. M., Gringeri, A., de Biasi, R., Baudo, F., Morfini, M. & Ciavarella, N., 1992. Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate. Thrombosis and Haemostasis 67:310-313. Marx, J. L., 1983. Human T-cell virus linked to AIDS. Science 220:806-809. Masquelier, B., Faivre, R., Paty, M. C. & Fleury, H. J. A., 1992. HIV1 quantitation in infected patients: a comparison of cell viraemia, plasma viraemia and R-HEV. Res. Virol. 143:17-22. Matsuda, J., Gohchi, K., Tsukamoto, M., Saitoh, N. & Kinoshita, T., 1993. High prevalence of anti-cardiolipin antibody, C1q-, C3d- and mRF-IgG immune complexes, and anti-nuclear antibody in hemophiliacs irrespective of infection with human immunodeficiency virus type 1. J. Acquir. Immune Defic. Syndr. 6:1120-1124. Matthews, T. J. & Bolognesi, D. P., 1988. AIDS vaccines. Sci. Am. 259:98-105. McKeating, J. A. & Moore, J. P., 1991. HIV infectivity. Nature 349:660. Melbye, M., Biggar, R. J., Chermann, J. C., Montagnier, L., Stenbjerg, S. & Ebbesen, P., 1984. High prevalence of lymphandenopathy virus (LAV) in European haemophiliacs. Lancet II:40-41. Mendenhall, C. L., Roselle, G. A., Grossman, C. J., Rouster, S. D. & Weener, R. E., 1986. False Positive Tests for HTLV-III Antibodies in Alcoholic Patients with Hepatitis. NEJM 314:921-922. Michael, N. L., Chang, G., Ehrenberg, P. K., Vahey, M. T. & Redfield, R. R., 1993. HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences. J. Acquir. Immune Defic. Syndr. 6:1073-1085. Michaelis, B. A. & Levy, J. A., 1987. Recovery of human immunodeficiency virus from serum. JAMA 257:1327. Minassian, A., Merges, M., Garrity, R., Nagashima, K., Tsai, W. P., Oroszlan, S. & Nara, P., 1993. Induction of a SMRV-like retrovirus from a human T-cell line after treatment with the mutagen ethyl-methyl-sulfonate. J. Acquir. Immune Defic. Syndr. 6:738. Mitsuya, H. & Broder, S., 1989. Antiretroviral chemotherapy against human immunodeficiency virus (HIV) infection: perspective for therapy of hepatitis B virus infection. Cancer Detect. Prev. 14:299-308. Moffat, E. H., Bloom, A. L. & Mortimer, P. P., 1985. HTLV-III antibody status and immunological abnormalities in haemophilic patients. Lancet I:935. Montagnier, L., 1985. Lymphadenopathy-Associated Virus: From Molecular Biology to Pathogenicity. Ann. Int. Med. 103:689-693. Moore, J. P. & Nara, P. L., 1991. The role of the V3 loop and gp120 in HIV infection. AIDS 5:S21-S33. Mortimer, P. P., 1989. The AIDS virus and the AIDS test. Med. Internat. 56:2334-2339. Moss, A. R., Bacchetti, P., Osmond, D., Krampf, W., Chaisson, R. E., Stites, D., Wilber, J., Allain, J. P. & Carlson, J., 1988. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco cohort. Br. Med. J. 296:745-750. Muller, G., 1960. Interstitielle plasmacellulare Pneumonie nach Corticosteroidbehandlung. Frankfurter Zeitschrift Pathologie 70:657-675. Natoli, C., Dianzani, F., Mazzotta, F., Balocchini, E., Peirotti, P., Antonelli, G. & Icaobelli, S., 1993. 90K Protein: A New Predictor Marker of Disease Progression in Human Immunodeficiency Virus Infection. J. Acquir. Immune Defic. Syndr. 6:370-375. Neumann, P., O'Shaughnessy, M., Remis, R., Tsoukas, C., Lepine, D. & Davis, M., 1990. Laboratory evidence of active HIV-1 infection in Canadians with hemophilia associated with administration of heat-treated factor VIII. J. Acquir. Immune Defic. Syndr. 3:278-281. Neurath, A. R., Strick, N. & Sproul, P. S. O., 1992. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J. Exp. Med. 175:461-469. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P. & Fauci, A. S., 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358. Papadopulos-Eleopulos, E., 1982. A Mitotic Theory. J. Theor. Biol. 96:741-758. Papadopulos-Eleopulos, E., 1988. Reappraisal of AIDS: Is the oxidation caused by the risk factors the primary cause? Med. Hypotheses 25:151-162. Papadopulos-Eleopulos, E., Turner, V. F. & Papadimitriou, J. M., 1992. Oxidative Stress, HIV and AIDS. Res. Immunol. 143:145-148. Papadopulos-Eleopulos, E., Turner, V. F. & Papadimitriou, J. M., 1993a. Is a Positive Western Blot Proof of HIV Infection? Bio/Technology 11:696-707. Papadopulos-Eleopulos, E., Turner, V. F. & Papadimitriou, J. M., 1993b. Has Gallo proven the role of HIV in AIDS? Emerg. Med. [Australia] 5:113-123. Papadopulos-Eleopulos, E., Turner, V. F., Papdimitriou, J. M., Causer, D., Hedland-Thomas, B. & Page, B., 1994. A critical analysis of the HIV-T4-cell-AIDS hypothesis. Genetica 95:25-50. Parmentier, H. K., van Wichen, D. F., Gmelig Meyling, F. H. J., Goudsmit, J. & Schuurman, H. J., 1992. Epitopes of human immunodeficiency virus regulatory proteins tat, nef, and rev are expressed in normal human tissue. Am. J. Pathol. 141:1209-1216. Popovic, M., Sarngadharan, M. G. & Read, E., 1984. Detection, Isolation,and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS. Science 224:497-500. Ragni, M. V., Lewis, J. H., Spero, J. A. & Bontempo, F. A., 1983. Acquired-immunodeficiency-like syndrome in two hemophiliacs. Lancet I:213-214. Rahemtulla, A., Durrant, S. T. S. & Hows, J. M., 1986. Subacute encephalopathy associated with human immunodeficiency virus in haemophilia A. Br. Med. J. 293:993. Ramsey, R. B., Palmer, E. L., McDougal, J. S., Kalyanaraman, V. S., Jackson, D. W., Chorba, T. L., Holman, R. C. & Evatt, B. L., 1984. Antibody to lymphadenopathy-associated virus in haemophiliacs with and without AIDS. Lancet II:397-398. Redfield, R. R. & Burke, D. S., 1988. HIV infection: the clinical picture. Sci. Am. 259:70-78. Remis, R. S., O'Shaughnessy, M. V., Tsoukas, C., Growe, G. H., Schechter, M. T., Palmer, R. W. H. & Lawrence, D. N., 1990. HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate. Can. Med. Assoc. J. 1247-1254. Rizza, C. R. & Spooner, R. J. D., 1983. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom. Br. Med. J. 286:929-933. Robert-Guroff, M., Schrecker, A. W., Brinkman, B. J. & Gallo, R. C., 1977. DNA polymerase y of human lymphoblasts. Biochem. 16:2866-2873. Rosenberg, Z. F. & Fauci, A. S., 1990. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol. Today 11:176-180. Sarngadharan, M. G., Robert-Guroff, M. & Gallo, R. C., 1978. DNA polymerases of normal and neoplastic mammalian cells. Biochim. Biophysica. Acta. 516:419-487. Sarria, L., Gallego, L., de las Heras, B., Basaras, M. & Cisterna, R. S. O., 1993. Production of hepatitis B virus from peripheral blood lymphocytes stimulated with phytohemagglutinin. Enferm. Infect. Microbiol. Clin. 11:187-189. Schneider, T. S., Beck, A. B., Ropke, C., Ullrich, R., Harthus, H. P., Broker, M. & Pauli, G., 1993. The HIV-1 Nef protein shares an antigenic determinant with a T-cell surface protein. AIDS 7:647-654. Schneweis, K. E., Ackermann, A., Friedrich, A., Kleim, J. P., Kornau, K. & Ruff, R., 1989. Comparison of different methods for detecting human immune deficiency virus in human immunodeficiency virus-seropositive hemophiliacs. J. Med. Virol. 29:94-101. Schneweis, K. E., Kleim, J. P., Bailly, E., Niese, D., Wagner, N. N. & Brackman, H. H., 1990. Graded cytopathogenicity of the human immunodeficiency virus (HIV) in the course of HIV infection. Med. Microbiol. Immunol. 179:193-203. Schupbach, J., Jendis, J. B., Bron, C., Boni, J. & Tomasik, Z., 1992. False-positive HIV-1 virus cultures using whole blood. AIDS 6:1545-1546. Sheppard, H. W., Ascher, M. S. & Krowka, J. F., 1993. Viral burden and HIV disease. Nature 364:291. Shoebridge, G. I., Barone, L., Wing-Simpson, A., Bennetts, B. H., Nighingale, B. N., Hensley, W. J. & Gatenby, P. A., 1991. Assessment of HIV status using the polymerase chain reaction in antibody-positive patients and high-risk antibody-negative haemophiliacs. AIDS 5:221-224. Simmonds, P., Beatson, D., Cuthbert, R. J. G., Watson, H., Reynolds, B., Peutherer, J. F., Parry, J. V., Ludlam, C. A. & Steel, C. M., 1991. Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet 338:1159-1163. Smith, D. K., Neal, J. J. & Holmberg, S.D., 1993. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. NEJM 328:373-379. Temin, H. M. & Baltimore, D., 1972. RNA-Directed DNA Synthesis and RNA Tumor Viruses. Adv. Vir. Res.17:129-186. Todaro, G. J., Benveniste, R. E. & Sherr, C. J. 1976. Interspecies Transfer of RNA Tumour Virus Genes: Implications for the search for "Human" Type C Viruses. pp. 369-384, in Animal Virology, edited by D. Baltimore, A. S. Huang and C. S. Fox, Academic Press Inc., New York. Touchette, N., 1993. HBV-drug deaths prompt restudy of similar antivirals. J. NIH Res. 5:33-35. Toyoshima, K. & Vogt, P. K., 1969. Enhancement and Inhibition of Avian Sarcoma Viruses by Polycations and Polyanions. Virol.38:414-426. Tsoukas, C., Gervais, F., Shuster, J., Gold, P., O'Shaughnessy, M. & Robert-Guroff, M., 1984. Association of HTLV-III Antibodies and Cellular Immune Status of Hemophiliacs. NEJM 311:1514-1515. van Aken, W. G. 1991. Preparation of plasma derivatives. pp. 323-333, in Principles of Transfusion Medicine, edited by E. C. Rossi, T. L. Simon and G. S. Moss, WIlliams and Wilkins, Baltimore. van den Berg, W., Ten Cate, J. W., Breederveld, C. & Goudsmit, J., 1986. Seroconversion to HTLV-III in haemophiliac given heat-treated factor VIII concentrate. Lancet I:803-804. Varmus, H., 1987. Reverse Transcription. Sci. Am. 257:48-54. Varmus, H., 1988. Retroviruses. Science 240:1427-1435. Varmus, H. & Brown, P. 1989. Retroviruses. pp. 53-108, in Mobile DNA, edited by D. E. Berg and M. M. Howe, American Society for Microbiology, Washington D.C. Varmus, H. E., 1989. Reverse transcription in bacteria. Cell 56:721-724. Vegnente, A., Guida, S., Lobo-Yeo, A., Alviggi, L., Daniels, H., Toscano, P., Nuzzo, V., Mieli-Vergani, G. & Vergani, D. S. O., 1991. T lymphocyte activation is associated with viral replication in chronic hepatitis B virus infection of childhood. Clin. Exp. Immunol. 84:190-194. Vilmer, E., Rouzioux, C., Vezinet Brun, F., Fischer, A., Chermann, J. C., Barre-Sinoussi, F., Gazengel, C., Dauguet, C., Manigne, P. & Griscelli, C., 1984. Isolation of new lymphotropic retrovirus from two siblings with Haemophilia B, one with AIDS. Lancet I:753-757. Vincent, F., Belec, L., Glotz, D., Menoyo-Calonge, V., Dubost, A. & Bariety, J., 1993. False-positive neutralizable HIV antigens detected in organ transplant recipients. AIDS 7:741-742. Wagner, N., Bialek, R., Radinger, H., Becker, M., Schneweis, K. E., Brackman, H. H. & Niese, D., 1990. HIV-1 infection in a cohort of haemophiliac patients. Arhiv. Dis. Childhood 65:1301-1304. Wain-Hobson, S., 1989. HIV genome variability in vivo. AIDS 3:S13-S18. Watson, K. F., Molling, K., Gelderblom, H. & Bauer, H., 1974. Oncornavirus-like particles in HeLa cells. III. Biochemical characterization of the virus. Int. J. Cancer 13:262-267. Weber, J. & Ariyoshi, K., 1992. Lack of correlation between acidified HIV p24 antigen and plasma viraemia. AIDS 6:428-429. Weber, J. N. & Weiss, R. A., 1988. HIV infection: the cellular picture. Sci. Am. 259:80-87. Weiss, R., Teich, N., Varmus, H. & Coffin, J., Ed. 1982. RNA Tumor Viruses. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory. Weissbach, A., Baltimore, D., Bollum, Gallo, R.C. & Korn, D., 1975. Nomenclature of eukaryotic DNA polymerases. Science 190:401-402. WHO, 1986. Acquired Immunodeficiency Syndrome (AIDS) WHO/CDC case definition for AIDS. Wkly. Epidem. Rec. 61:69-76. WHO, 1988. Acquired Immunodeficiency Syndrome (AIDS) 1987 revision of CDC/WHO case definition for AIDS. Wkly. Epidem. Rec. 63:1-8. Wong-Staal, F. & Gallo, R. C., 1985. Human T-lymphotropic retroviruses. Nature 317:395-403. Wu, T. C., Kanayama, M. D., Hruban, R. H., Whitehead, W. & Raj, B. K., 1993. Detection of a neuron-specific 9.0-kb transcript which shares homology with antisense transcripts of HIV-1 gag gene in patients with and without HIV-1 infection. Am. J. Pathol. 142:25-31. Zhang, L. Q., Simmonds, P., Ludlam, C. A. & Leigh Brown, A. J., 1991. Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS 5:675-681.
|